Skip to main content
Center of Excellence in Urology & Men's Health (Pattaya, Chonburi, Rayong)
PreventionVideo Guide6 min read

Elevated PSA, Multiparametric Prostate MRI (PI-RADS) & PSMA PET Scan: Modern Prostate Cancer Screening Guide

Synthesizing Dr. Niti’s complete 8-episode Prostate Cancer Series: why early prostate cancer has zero symptoms, when to start PSA blood screening, how MRI PI-RADS avoids unnecessary biopsies, and how PSMA PET scans stage disease.

Elevated PSA, Multiparametric Prostate MRI (PI-RADS) & PSMA PET Scan: Modern Prostate Cancer Screening Guide
Specialist Video Guide · Dr. Niti Navanimitkul

Elevated PSA to MRI Fusion & Modern Staging | Dr. Niti Prostate Cancer Pathway

@Dr.Niti-ProstateMensHealth

Video Chapters & Key Moments (Click to Jump)

Modern 5-Step Prostate Cancer Diagnostic & Care Pathway

  1. PSA Blood Screening: Catches silent early tumors before symptoms appear (start age 50, or 40–45 with family history).
  2. Multiparametric MRI (PI-RADS 1–5): Performed before biopsy to avoid unnecessary needles when benign and pinpoint high-risk targets.
  3. Targeted MRI Fusion Biopsy: Replaces blind 12-core sampling with millimeter-accurate lesion confirmation.
  4. PSMA PET-CT Molecular Staging: Detects whole-body lymph node or bone spread in intermediate/high-risk cases with unmatched sensitivity.
  5. Risk-Tailored Treatment: Active surveillance, nerve-sparing focal therapy (IRE NanoKnife), radical surgery, radiotherapy (+ spacer), or modern systemic therapy for advanced stages.

Why can a healthy, athletic 58-year-old man with zero urinary complaints be diagnosed with prostate cancer during an annual checkup? Across his acclaimed 8-Episode Prostate Cancer Education Series, Dr. Niti Navanimitkul (ว.29673) demystifies every step from your first PSA blood test through MRI PI-RADS scoring, MRI fusion biopsy, PSMA PET scanning, and tailored treatment at every stage.

Understanding Your Prostate MRI PI-RADS Score (1 to 5)

PI-RADS Score Chance of Significant Cancer Typical Next Clinical Step
PI-RADS 1 – 2 Very low / Low Often avoid immediate biopsy; monitor PSA & PSA density
PI-RADS 3 Equivocal (borderline) Combine with PSA density, clinical exam & shared decision-making
PI-RADS 4 – 5 High / Very high Proceed to targeted MRI-Ultrasound Fusion Prostate Biopsy

Every Stage Has Effective Options

Not every localized prostate cancer requires immediate surgery: low-risk tumors can be safely monitored with Active Surveillance, single-spot low-to-intermediate tumors may suit Focal Therapy (IRE NanoKnife), clinically significant localized cancers are cured with robotic/radical prostatectomy or precision radiotherapy, and even metastatic disease discovered on PSMA PET-CT responds remarkably well to modern systemic therapies. Schedule your PSA screening or second-opinion MRI review with Dr. Niti at M-Trust Urology Clinic Pattaya.

Frequently Asked Clinical Questions

Does early-stage prostate cancer cause urinary symptoms, and when should men check PSA?
Early curable prostate cancer usually grows in the outer peripheral zone of the gland and causes ZERO urinary symptoms. A single tube of blood for PSA screening is typically discussed starting at age 50 (or age 40–45 for men with a family history of prostate/BRCA-related cancers).
If my PSA is elevated, do I need an immediate biopsy, and what is a PI-RADS score?
Not immediately! Elevated PSA can also stem from benign BPH enlargement, prostatitis inflammation, or recent ejaculation/cycling. Today, multiparametric Prostate MRI is performed first and scored from PI-RADS 1–2 (low likelihood, often avoiding biopsy) to PI-RADS 3 (equivocal) and PI-RADS 4–5 (high likelihood, guiding targeted MRI Fusion Biopsy).
What is a PSMA PET scan, and can metastatic prostate cancer still be treated?
PSMA PET-CT uses a molecular tracer that binds specifically to Prostate-Specific Membrane Antigen on prostate cancer cells across the entire body—detecting tiny lymph node or bone spread far earlier than conventional CT and bone scans. Even if prostate cancer has spread, modern systemic hormone, targeted, radioligand, and combination therapies effectively control disease and extend quality life.

Ready to Start?